ClinicalTrials.Veeva

Menu

Analysis of Expression of Nitric Oxide Syntheses and Their Functional Role in Human Urothelium

C

Copenhagen University Hospital at Herlev

Status

Terminated

Conditions

Interstitial Cystitis
Bladder Diseases
Urinary Incontinence

Treatments

Procedure: Tissue examination for protein- and mRNA-expression of NO

Study type

Observational

Funder types

Other

Identifiers

NCT00253006
UA_H_Ka-05104-m

Details and patient eligibility

About

Painful bladder syndrome (PBS)/interstitial cystitis (IC) may be due to the actions of nitric oxide (NO) in the bladder tissue. NO is a gaseous substance with a very short half-life, synthesized by a group of NO-synthase-enzymes in many tissues.

The goal of this study is to illuminate bladder tissue production of NO in individuals with PBS and healthy individuals, by quantification of NO and NO-enzyme expression by different molecular biological methods.

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • PBS/IC according to International Continence Society (ICS)
  • Cystoscopy with bladder distension and deep biopsies within last 5 years
  • Cystometry within last 5 years
  • Normal urine culture within last month

Inclusion Criteria (for control group):

  • Benign non-invasive bladder disease
  • No PBS/IC
  • Normal urine culture
  • No functional bladder disease of known nature (ex. infravesical obstruction)

Exclusion criteria

  • Age under 18 years
  • Inability to understand instructions
  • Pregnancy and lactation

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems